Regional distribution of protein and activity of the nitric oxide receptor, soluble guanylyl cyclase, in rat brain suggests multiple mechanisms of regulation

Brain Research

Volumn 950, Issue 1-2, 2002, Pages 148-154

  Nedvetsky, Pavel I ^a,b   Kleinschnitz, Christoph ^b   Schmidt, Harald H H W ^a,b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

cGMP; Diethylamine NONOate; Nitric oxide donor; Sodium nitroprusside

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE DONOR; NITRIC OXIDE RECEPTOR; NITROPRUSSIDE SODIUM; PROTEIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBUNIT; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BRAIN; CYCLIC GMP; DIMERIZATION; GUANYLATE CYCLASE; MALE; NITRIC OXIDE DONORS; PROTEIN BIOSYNTHESIS; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 0037144169     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03015-9     Document Type: Article

References (53)

1. Ariano M.A., Lewicki J.A., Brandwein H.J., Murad F. Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc. Natl. Acad. Sci. USA. 79:1982;1316-1320.
2. Artz J.D., Toader V., Zavorin S.I., Bennett B.M., Thatcher G.R. In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics. Biochemistry. 40:2001;9256-9264.
3. Bellamy T.C., Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 276:2000;4287-4292.
4. Boulton C.L., Southam E., Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703.
5. Boulton C.L., Irving A.J., Southam E., Potier B., Garthwaite J., Collingridge G.L. The nitric oxide - cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci. 6:1994;1528-1535.
6. Boxall A.R., Garthwaite J. Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase. Eur. J. Neurosci. 8:1996;2209-2212.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Brandes R.P., Kim D., Schmitz-Winnenthal F.H., Amidi M., Godecke A., Mulsch A., Busse R. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 35:2000;231-236.
9. Burgunder J.M., Cheung P.T. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur. J. Neurosci. 6:1994;211-217.
10. Dierks E.A., Burstyn J.N. Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem. Pharmacol. 51:1996;1593-1600.
11. Feelisch M., Stamler J.S. Donors of Nitrogen Oxides. 1996;71-115 Wiley, New York.
12. Feelisch M., Kotsonis P., Siebe J., Clement B., Schmidt H.H.H.W. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Mol. Pharmacol. 56:1999;243-253.
13. Ferrero R., Rodriguez-Pascual F., Miras-Portugal M.T., Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J. Neurochem. 75:2000;2029-2039.
14. Furuyama T., Inagaki S., Takagi H. Localizations of alpha 1 and beta 1 subunits of soluble guanylate cyclase in the rat brain. Brain Res. Mol. Brain Res. 20:1993;335-344.
15. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
16. Gibb B.J., Garthwaite J. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13:2001;539-544.
17. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:1966;655-669.
18. Gordge M.P., Hothersall J.S., Noronha-Dutra A.A. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol. 124:1998;141-148.
19. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62:1994;807-810.
20. Gupta G., Azam M., Yang L., Danziger R.S. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J. Clin. Invest. 100:1997;1488-1492.
21. Harteneck C., Wedel B., Koesling D., Malkewitz J., Bohme E., Schultz G. Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett. 292:1991;217-222.
22. Ibarra C., Nedvetsky P.I., Gerlach M., Riederer P., Schmidt H.H. Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain. Brain Res. 907:2001;54-60.
23. Kendrick K.M., Guevara-Guzman R., Zorrilla J., Hinton M.R., Broad K.D., Mimmack M., Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature. 388:1997;670-674.
24. Koglin M., Vehse K., Budaeus L., Scholz H., Behrends S. Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J. Biol. Chem. 276:2001;30737-30743.
25. Koppenol W.H. Thermodynamics of reactions involving nitrogen-oxygen compounds. Methods Enzymol. 268:1996;7-12.
26. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds [see comments]. Nature. 364:1993;626-632.
27. Louis J.C., Revel M.O., Zwiller J. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim. Biophys. Acta. 1177:1993;299-306.
28. Markerink-Van Ittersum M., Steinbusch H.W.M., De Vente J. Region-specific developmental patterns of atrial natriuretic factor- and nitric oxide-activated guanylyl cyclases in the postnatal frontal rat brain. Neuroscience. 78:1997;571-587.
29. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360.
30. McGehee D.S., Goy M.F., Oxford G.S. Involvement of the nitric oxide-cyclic GMP pathway in the desensitization of bradykinin responses of cultured rat sensory neurons. Neuron. 9:1992;315-324.
31. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
32. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1986;1-5.
33. Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent. Prog. Horm. Res. 49:1994;239-248.
34. Nakane M., Ichikawa M., Deguchi T. Light and electron microscopic demonstration of guanylate cyclase in rat brain. Brain Res. 273:1983;9-15.
35. Prast H., Tran M.H., Fischer H., Philippu A. Nitric oxide-induced release of acetylcholine in the nucleus accumbens: role of cyclic GMP, glutamate, and GABA. J. Neurochem. 71:1998;266-273.
36. Russwurm M., Behrends S., Harteneck C., Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335:1998;125-130.
37. Russwurm M., Wittau N., Koesling D. Guanylyl cyclase/PSD-95 interaction:targeting of the NO-sensitive alpha{sub2}beta{sub1} guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276:2001;44647-44652.
38. Sakaue M., Kuno T., Tanaka C. Novel type of monoclonal antibodies against cyclic GMP and application to immunocytochemistry of the rat brain. Jpn. J. Pharmacol. 48:1988;47-56.
39. Schmidt H.H.H.W., Gagne G.D., Nakane M., Pollock J.S., Miller M.F., Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J. Histochem. Cytochem. 40:1992;1439-1456.
40. Schmidt K., Schrammel A., Koesling D., Mayer B. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells. Mol. Pharmacol. 59:2001;220-224.
41. Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 349:1991;326-328.
42. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
43. Thompson S.H. Cyclic GMP-gated channels in a sympathetic neuron cell line. J. Gen. Physiol. 110:1997;155-164.
44. Tseng C.M., Tabrizi-Fard M.A., Fung H.L. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J. Pharmacol. Exp. Ther. 292:2000;737-742.
45. de Vente J., Steinbusch H.W.M. On the stimulation of soluble and particulate guanylate cyclase in the rat brain and the involvement of nitric oxide as studied by cGMP immunocytochemistry. Acta Histochem. 92:1992;13-38.
46. de Vente J., Hopkins D.A., Markerink-van Ittersum M., Steinbusch H.W.M. Effects of the 3′,5′-phosphodiesterase inhibitors isobutylmethylxanthine and zaprinast on NO-mediated cGMP accumulation in the hippocampus slice preparation: an immunocytochemical study. J. Chem. Neuroanat. 10:1996;241-248.
47. de Vente J., Hopkins D.A., Markerink-Van Ittersum M., Emson P.C., Schmidt H.H.H.W., Steinbusch H.W.M. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience. 87:1998;207-241.
48. de Vente J., Hopkins D.A., Markerink-van Ittersum M., Steinbusch H.W.M. Nitric oxide-mediated cGMP production in the islands of Calleja in the rat. Brain Res. 789:1998;175-178.
49. Wink D.A., Cook J.A., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M.C., Mitchell J.B. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys. 331:1996;241-248.
50. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
51. Zabel U., Weeger M., La M., Schmidt H.H.H.W. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem. J. 335:1998;51-57.
52. Zabel U., Hausler C., Weeger M., Schmidt H.H.H.W. Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione S-transferase affinity tag. J. Biol. Chem. 274:1999;18149-18152.
53. Zabel U., Kleinschnitz C., Oh P., Nedvetsky P., Smolenski A., Muller H., Kronich P., Kugler P., Walter U., Schnitzer J.E., Schmidt H.H. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell. Biol. 4:2002;307-311.